Papers matching “immune checkpoint blockade” 183
Not finding it? Sign in to also search OpenAlex live.
-
Neoadjuvant immune checkpoint blockade in mismatch repair deficient endometrial cancer: An update on recurrence-free survival and correlative biomarkers.2024 Journal of Clinical Oncology conference-abstract Medicine Endometrial and Cervical Cancer Treatments
Marco de Bruyn, Anneke L. Eerkens, Koen Brummel, Annegé Vledder, Sterre T. Paijens, Marta Requesens, +14 more
1citations -
P2RY2 is a purinergic immune checkpoint linking extracellular ATP to immune evasion and adaptive resistance to immunotherapy2025 bioRxiv (Cold Spring Harbor Laboratory) preprint Biochemistry, Genetics and Molecular Biology Adenosine and Purinergic Signaling Open access
Zhaoqing Hu, Shangce Du, Cecilia Berzain Battioni, Lena Jassowicz, Rafael Carretero, Melanie Sator‐Schmitt, +8 more
2citations -
Immune checkpoint inhibition combined with targeted therapy using a novel virus-like drug conjugate induces complete responses in a murine model of local and distant tumors2023 Cancer Immunology Immunotherapy article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 1 patent
Ruben V. Huis in ‘t Veld, Sen Ma, Rhonda C. Kines, Anneli Savinainen, Cadmus Collins Rich, FERRY A. OSSENDORP, +1 more
19citations -
Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer2021 Journal of Translational Medicine article Medicine PARP inhibition in cancer therapy Open access cited by 1 patent
Jinyu Meng, Jin Peng, Jie Feng, Jochen Maurer, Xiao Li, Yan Li, +11 more
63citations -
Myeloid reprogramming by JAK inhibition enhances checkpoint blockade therapy2022 bioRxiv (Cold Spring Harbor Laboratory) preprint Immunology and Microbiology Immune cells in cancer Open access
Jaroslav Žák, Isaraphorn Pratumchai, Brett S. Marro, Kristi Marquardt, Reza Beheshti Zavareh, Luke L. Lairson, +4 more
6citations -
Blockade of the CD47/SIRPα checkpoint axis potentiates the macrophage-mediated antitumor efficacy of tafasitamab2024 Haematologica article Immunology and Microbiology Phagocytosis and Immune Regulation Open access
Alexander Biedermann, Maria Patra-Kneuer, Dimitrios Mougiakakos, Maike J. Büttner-Herold, Doris Mangelberger-Eberl, Johannes Berges, +14 more
6citations -
Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition2025 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Cancer Immunotherapy and Biomarkers Open access
Noah F. Greenwald, Iris Nederlof, Daisy Yi Ding, Seongyeol Park, Alex Kong, Kathleen E. Houlahan, +29 more
7citations -
A prediction model for response to immune checkpoint inhibition in advanced melanoma.2023 Journal of Clinical Oncology conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access
Isabella A.J. van Duin, Rik Jasper Verheijden, P. J. van Diest, Alfonsus Johannes Maria van den Eertwegh, Jan Willem de Groot, Olivier Jules van Not, +14 more
0citations -
Checkpoint Blockade Combinations in Tumor Mutational Burden/Load-High Tumors: Insights from the Atezolizumab + Bevacizumab and Nivolumab + Ipilimumab Cohorts in the Drug Rediscovery Protocol
Karlijn Verkerk, Soemeya F. Haj Mohammad, Laurien Joanna Zeverijn, Birgit S. Geurts, Ilse A.C. Spiekman, Florentine A.J. Verbeek, +12 more
2citations -
OX40 agonism enhances efficacy of PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum2021 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Cancer Immunotherapy and Biomarkers Open access
Guillaume Beyrend, Tetje Cornelia van der Sluis, Esmé T.I. van der Gracht, Tamim Abdelaal, Simon P. Jochems, Robert A. Belderbos, +16 more
0citations -
Blood-based kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage NSCLC: the prospective IOpener study2026 Journal for ImmunoTherapy of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access
Karlijn de Joode, Harry J.M. Groen, Michel M. van den Heuvel, Jeroen S. Kloover, Femke S. van der Meer, Cor H. van der Leest, +12 more
0citations -
Progenitor exhausted PD-1+ T cells are cellular targets of immune checkpoint inhibition in atherosclerosis2025 Nature Cardiovascular Research article Immunology and Microbiology Atherosclerosis and Cardiovascular Diseases Open access
Megan Mulholland, Anthi Chalou, Marie A.C. Depuydt, Yinda Yu, Shiying Lin, Klara Tallbäck, +10 more
17citations